Back

Physicians’ Education Resource

  • Complement Inactivating Agents
  • Glomerulonephritis, IGA

Burst CME(TM) Part V: Complement Inhibitors in IgAN

Guidelines for the management of IgA nephropathy; new and emerging IgA nephropathy treatments; therapies targeting the 4-hit pathophysiology of IgA nephropathy

Credit & MOC Details

Credit information is provided by the course provider. We recommend confirming credit eligibility with the provider or your licensing board before starting the activity.

Credit types

AMA PRA Category 1 Credit™Up to 0.25 credits

MOC types

No MOC

FDA REMS

No

Qualifies for MIPS

No

Pricing

Free

Reported to ACCME by the provider

  • Enduring / On-demand
  • Credit · Up to 0.25 credits
  • Commercial Support
  • Released
    Jun 30, 2026
  • Last day to claim credit
    Jul 1, 2027 9 months left